首页 › B细胞淋巴瘤 › 田纳西州 › Nashville
Nashville TN B细胞淋巴瘤临床试验
11项针对 B细胞淋巴瘤的研究正在 Nashville及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma
招募中1/2 期
- Sarah Cannon Research Institute, Nashville
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
招募中3 期
- Tennessee Oncology Nashville St Thomas Midtown Clinic, Nashville
- Tennessee Oncology, Nashville
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
招募中1 期
- SCRI Oncology Partners, Nashville
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
招募中2 期
- Research Site, Nashville
Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL
招募中3 期
- SCRI Oncology Partners, Nashville
A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
招募中1/2 期
- Research Site, Franklin · 距离 17 英里
Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
招募中1/2 期
- SCRI Oncology Partners, Nashville
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
招募中1/2 期
- Vanderbilt University Medical Center, Nashville
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
招募中3 期
- Sarah Cannon Research Institute SCRI, Nashville
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
招募中3 期
- SCRI Oncology Partners, Nashville
DALY II USA/ MB-CART2019.1 for DLBCL
招募中2 期
- SCRI Oncology Partners, Nashville
其他城市的 B细胞淋巴瘤试验
- New York City, NY18 项研究
- Houston, TX16 项研究
- Chicago, IL13 项研究
- Philadelphia, PA11 项研究
- Rochester, MN10 项研究
- Baldwin Park, CA9 项研究
- Milwaukee, WI9 项研究
- Cleveland, OH9 项研究
- Boston, MA8 项研究
- Salt Lake City, UT8 项研究
- Washington, DC7 项研究
- Columbus, OH7 项研究
Nashville的其他研究
- 非小细胞肺癌97 项研究
- 乳腺癌81 项研究
- 转移性癌症70 项研究
- 结直肠癌69 项研究
- 癌症（所有类型）65 项研究
- 卵巢癌49 项研究
- 前列腺癌43 项研究
- 肺癌40 项研究
- 头颈鳞状细胞癌39 项研究
- 胰腺癌39 项研究
- 子宫内膜癌38 项研究
- 黑色素瘤33 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。